A novel translabial platform utilizing bioexcipients from Litchi chinesis for the delivery of rosiglitazone maleate

[1]  Y. Sung,et al.  Antiplatelet, anticoagulant and fibrinolytic effects of Litchi chinensis Sonn. extract. , 2011, Molecular medicine reports.

[2]  A. Bernkop‐Schnürch,et al.  Comparison of the mucoadhesive properties of various polymers. , 2005, Advanced drug delivery reviews.

[3]  Yong Wang,et al.  Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment. , 2004, Biomaterials.

[4]  R. Frye,et al.  Simplified method for determination of rosiglitazone in human plasma. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  N. Nafee,et al.  Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. , 2003, Acta pharmaceutica.

[6]  S. Saisivam,et al.  Design and Evaluation of Matrix Diffusion Controlled Transdermal Patches of Verapamil Hydrochloride , 2003, Drug development and industrial pharmacy.

[7]  M. Stewart,et al.  Thiazolidinediones for type 2 diabetes. All glitazones may exacerbate heart failure. , 2001, BMJ.

[8]  Ann K. Miller,et al.  Absorption, disposition, and metabolism of rosiglitazone, a potent thiazolidinedione insulin sensitizer, in humans. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[9]  Sean C. Sweetman,et al.  Martindale: The Complete Drug Reference , 1999 .

[10]  T. Redelmeier,et al.  Skin Barrier: Principles of Percutaneous Absorption , 1996 .

[11]  ヒッレ，トーマス,et al.  Transdermal therapeutic system to prevent poisoning by organophosphorus neurotoxin comprising a combination of active substances including parasympathomimetics and parasympathetic blockers , 1994 .

[12]  Christopher T. Rhodes,et al.  Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application , 1994 .

[13]  Y. Iwamoto,et al.  Effect of New Oral Antidiabetic Agent CS-045 on Glucose Tolerance and Insulin Secretion in Patients with NIDDM , 1991, Diabetes Care.

[14]  D. Coomans,et al.  Development and Testing of Bioadhesive, Fluoride‐containing Slow‐release Tablets for Oral Use , 1991, The Journal of pharmacy and pharmacology.

[15]  J. Robinson,et al.  Physico-chemical properties of water insoluble polymers important to mucin/epithelial adhesion☆ , 1985 .

[16]  江口 豊.  Advances in Transdermal Controlled Drug Administration for Systemic Medications , 1985 .

[17]  Brian W. Barry,et al.  Dermatological Formulations: Percutaneous Absorption , 1983 .

[18]  John H. Draize,et al.  METHODS FOR THE STUDY OF IRRITATION AND TOXICITY OF SUBSTANCES APPLIED TOPICALLY TO THE SKIN AND MUCOUS MEMBRANES , 1944 .

[19]  Y. Vishnu,et al.  Development of nitrendipine transdermal patches: in vitro and ex vivo characterization. , 2007, Current drug delivery.

[20]  Disciplinary Committee,et al.  Royal Pharmaceutical Society of Great Britain , 2002 .

[21]  P. Diwan,et al.  INFLUENCE OF CASTING SOLVENT ON THE PERMEABILITY OF ETHYL CELLULOSE FREE FILMS FOR TRANSDERMAL USE , 1997 .

[22]  James M. Anderson,et al.  Advances in Drug Delivery Systems , 1986 .